From Babylon to Berlin - Scorecard - MDSpire

From Babylon to Berlin

  • By

  • Hasan Chichan

  • May 26, 2026

  • 7 min

Share

Clinical Scorecard: From Babylon to Berlin

At a Glance

CategoryDetail
ConditionOphthalmic diseases, specifically cataracts and age-related macular degeneration (AMD)
Key MechanismsPhotobiomodulation (PBM) and subthreshold nanosecond laser (SNL) therapies for early intervention
Target PopulationPatients with cataracts, early and intermediate AMD, and diabetic retinopathy
Care SettingOperating theaters in Germany and humanitarian clinics in Iraq, Morocco, Egypt, and India

Key Highlights

  • High-volume surgical missions aim to establish sustainable local practices.
  • PBM and SNL are emerging therapies for early-stage AMD.
  • The gap between healthy and lost vision is critical in underserved areas.
  • The importance of early intervention over 'wait and watch' strategies.
  • Training local surgeons is essential for mission success.

Guideline-Based Recommendations

Diagnosis

  • Utilize triage clinics to identify appropriate surgical candidates.

Management

  • Implement PBM and SNL as non-invasive treatment options for early AMD.

Monitoring & Follow-up

  • Regular follow-ups for patients with early-stage diseases to prevent progression.

Risks

  • Delayed treatment can lead to irreversible vision loss.

Patient & Prescribing Data

Patients in rural and underserved regions with limited access to ophthalmic care.

PBM and SNL provide early intervention options before significant vision loss occurs.

Clinical Best Practices

  • Standardize surgical protocols and consent forms in local languages.
  • Focus on training local surgeons to ensure continuity of care.
  • Adopt a patient-centered approach during high-volume surgical days.

Related Resources & Content

    Original Source(s)

    Related Content